Erin Wright
Stock Analyst at Morgan Stanley
(4.38)
# 320
Out of 5,245 analysts
266
Total ratings
62.22%
Success rate
12.71%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CI The Cigna Group | Maintains: Overweight | $355 → $361 | $286.24 | +26.12% | 6 | May 20, 2026 | |
| HUM Humana | Maintains: Underweight | $146 → $217 | $307.95 | -29.53% | 7 | May 15, 2026 | |
| CVS CVS Health | Maintains: Overweight | $93 → $106 | $93.26 | +13.66% | 8 | May 14, 2026 | |
| OPCH Option Care Health | Maintains: Overweight | $38 → $28 | $20.93 | +33.78% | 3 | May 6, 2026 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $48 → $62 | $58.50 | +5.98% | 6 | May 6, 2026 | |
| HSIC Henry Schein | Maintains: Underweight | $61 → $64 | $74.21 | -13.76% | 7 | Apr 24, 2026 | |
| MOH Molina Healthcare | Maintains: Equal-Weight | $128 → $146 | $184.14 | -20.71% | 5 | Apr 24, 2026 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $19 → $21 | $23.43 | -10.37% | 10 | Apr 24, 2026 | |
| ALGN Align Technology | Maintains: Equal-Weight | $169 → $188 | $163.61 | +14.91% | 27 | Apr 24, 2026 | |
| PSX Phillips 66 | Upgrades: Overweight | $147 → $174 | $177.69 | -2.08% | 4 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $395 | $388.47 | +1.68% | 4 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $22 → $24 | $21.73 | +10.45% | 13 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $361 → $400 | $274.91 | +45.50% | 2 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $224 → $245 | $200.68 | +22.08% | 13 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $359 → $352 | $394.69 | -10.82% | 5 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $211 → $175 | $81.32 | +115.20% | 8 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $857 → $916 | $766.08 | +19.57% | 10 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $765 → $805 | $559.37 | +43.91% | 19 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $26 | $33.26 | -21.83% | 23 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3.5 → $3.2 | $2.12 | +50.94% | 12 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $10.21 | +125.27% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $195.21 | -11.89% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $259.93 | +15.42% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $8.12 | +417.24% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $172.00 | +67.44% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $160.30 | +119.59% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $4.40 | +900.00% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $432.80 | -58.18% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $103.00 | -83.50% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $20.73 | +483.70% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $448.28 | +29.38% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $5.24 | +567.94% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $116.78 | +75.54% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $17.11 | -35.71% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $167.90 | -6.49% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $533.24 | -42.24% | 1 | Oct 25, 2017 |
The Cigna Group
May 20, 2026
Maintains: Overweight
Price Target: $355 → $361
Current: $286.24
Upside: +26.12%
Humana
May 15, 2026
Maintains: Underweight
Price Target: $146 → $217
Current: $307.95
Upside: -29.53%
CVS Health
May 14, 2026
Maintains: Overweight
Price Target: $93 → $106
Current: $93.26
Upside: +13.66%
Option Care Health
May 6, 2026
Maintains: Overweight
Price Target: $38 → $28
Current: $20.93
Upside: +33.78%
BrightSpring Health Services
May 6, 2026
Maintains: Overweight
Price Target: $48 → $62
Current: $58.50
Upside: +5.98%
Henry Schein
Apr 24, 2026
Maintains: Underweight
Price Target: $61 → $64
Current: $74.21
Upside: -13.76%
Molina Healthcare
Apr 24, 2026
Maintains: Equal-Weight
Price Target: $128 → $146
Current: $184.14
Upside: -20.71%
Envista Holdings
Apr 24, 2026
Maintains: Equal-Weight
Price Target: $19 → $21
Current: $23.43
Upside: -10.37%
Align Technology
Apr 24, 2026
Maintains: Equal-Weight
Price Target: $169 → $188
Current: $163.61
Upside: +14.91%
Phillips 66
Apr 24, 2026
Upgrades: Overweight
Price Target: $147 → $174
Current: $177.69
Upside: -2.08%
Apr 22, 2026
Maintains: Overweight
Price Target: $375 → $395
Current: $388.47
Upside: +1.68%
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $22 → $24
Current: $21.73
Upside: +10.45%
Jan 29, 2026
Upgrades: Overweight
Price Target: $361 → $400
Current: $274.91
Upside: +45.50%
Jan 29, 2026
Maintains: Overweight
Price Target: $224 → $245
Current: $200.68
Upside: +22.08%
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $359 → $352
Current: $394.69
Upside: -10.82%
Nov 10, 2025
Maintains: Overweight
Price Target: $211 → $175
Current: $81.32
Upside: +115.20%
Nov 6, 2025
Maintains: Overweight
Price Target: $857 → $916
Current: $766.08
Upside: +19.57%
Nov 4, 2025
Maintains: Overweight
Price Target: $765 → $805
Current: $559.37
Upside: +43.91%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $33.26
Upside: -21.83%
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $2.12
Upside: +50.94%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $10.21
Upside: +125.27%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $195.21
Upside: -11.89%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $259.93
Upside: +15.42%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $8.12
Upside: +417.24%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $172.00
Upside: +67.44%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $160.30
Upside: +119.59%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $4.40
Upside: +900.00%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $432.80
Upside: -58.18%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $103.00
Upside: -83.50%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $20.73
Upside: +483.70%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $448.28
Upside: +29.38%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $5.24
Upside: +567.94%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $116.78
Upside: +75.54%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $17.11
Upside: -35.71%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $167.90
Upside: -6.49%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $533.24
Upside: -42.24%